David A Silbersweig, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurosciences | 7 | 2023 | 366 | 1.860 |
Why?
|
| Limbic System | 8 | 2011 | 419 | 1.760 |
Why?
|
| Emotions | 20 | 2022 | 2738 | 1.460 |
Why?
|
| Frontal Lobe | 8 | 2017 | 1420 | 1.410 |
Why?
|
| Brain Mapping | 41 | 2015 | 6626 | 1.120 |
Why?
|
| Somatoform Disorders | 2 | 2022 | 423 | 1.030 |
Why?
|
| Mental Disorders | 11 | 2024 | 6839 | 1.010 |
Why?
|
| Hallucinations | 9 | 2022 | 366 | 0.990 |
Why?
|
| Brain | 44 | 2023 | 27103 | 0.980 |
Why?
|
| Gyrus Cinguli | 8 | 2013 | 1115 | 0.980 |
Why?
|
| Psychiatry | 5 | 2021 | 1690 | 0.950 |
Why?
|
| Neuropsychiatry | 2 | 2015 | 76 | 0.940 |
Why?
|
| Tomography, Emission-Computed | 26 | 2001 | 1122 | 0.930 |
Why?
|
| Nerve Net | 11 | 2021 | 2288 | 0.870 |
Why?
|
| Amygdala | 10 | 2019 | 1353 | 0.840 |
Why?
|
| Prefrontal Cortex | 13 | 2021 | 2219 | 0.820 |
Why?
|
| Ultrasonic Therapy | 1 | 2023 | 215 | 0.750 |
Why?
|
| Needs Assessment | 3 | 2016 | 1139 | 0.750 |
Why?
|
| Psychotherapy | 5 | 2023 | 1647 | 0.740 |
Why?
|
| Conversion Disorder | 2 | 2014 | 202 | 0.690 |
Why?
|
| Awareness | 3 | 2024 | 647 | 0.680 |
Why?
|
| Mental Processes | 4 | 2006 | 244 | 0.680 |
Why?
|
| Physicians, Primary Care | 3 | 2016 | 623 | 0.660 |
Why?
|
| Migraine Disorders | 3 | 2016 | 1700 | 0.640 |
Why?
|
| Central Nervous System Diseases | 1 | 2023 | 520 | 0.630 |
Why?
|
| Magnetic Resonance Imaging | 52 | 2022 | 36430 | 0.610 |
Why?
|
| Encephalitis | 3 | 2022 | 438 | 0.530 |
Why?
|
| Borderline Personality Disorder | 6 | 2015 | 768 | 0.520 |
Why?
|
| Fear | 7 | 2015 | 1476 | 0.510 |
Why?
|
| Auditory Perception | 7 | 2005 | 583 | 0.500 |
Why?
|
| Schizophrenia | 13 | 2022 | 6937 | 0.500 |
Why?
|
| Psychomotor Performance | 8 | 2015 | 1879 | 0.440 |
Why?
|
| Epilepsy | 4 | 2024 | 3290 | 0.440 |
Why?
|
| Dominance, Cerebral | 8 | 2012 | 623 | 0.430 |
Why?
|
| Models, Psychological | 1 | 2017 | 828 | 0.420 |
Why?
|
| Semantics | 5 | 2021 | 601 | 0.420 |
Why?
|
| Psychophysiologic Disorders | 1 | 2014 | 221 | 0.420 |
Why?
|
| Program Development | 1 | 2019 | 1298 | 0.420 |
Why?
|
| Anesthetics, Intravenous | 1 | 2015 | 396 | 0.400 |
Why?
|
| Somatosensory Disorders | 1 | 2012 | 49 | 0.390 |
Why?
|
| Sex Characteristics | 3 | 2007 | 2637 | 0.390 |
Why?
|
| Positron-Emission Tomography | 9 | 2024 | 6478 | 0.390 |
Why?
|
| Panic Disorder | 4 | 2010 | 613 | 0.380 |
Why?
|
| Somatosensory Cortex | 3 | 2014 | 512 | 0.380 |
Why?
|
| Memory | 3 | 2015 | 2187 | 0.380 |
Why?
|
| Models, Neurological | 2 | 2017 | 1767 | 0.380 |
Why?
|
| Verbal Behavior | 4 | 2007 | 335 | 0.370 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2016 | 4014 | 0.360 |
Why?
|
| Hydrocortisone | 2 | 2009 | 1815 | 0.360 |
Why?
|
| Movement Disorders | 1 | 2014 | 459 | 0.360 |
Why?
|
| Education, Medical, Continuing | 1 | 2016 | 824 | 0.360 |
Why?
|
| Hippocampus | 6 | 2015 | 3763 | 0.350 |
Why?
|
| Nervous System Diseases | 2 | 2017 | 1665 | 0.340 |
Why?
|
| Propofol | 1 | 2015 | 603 | 0.330 |
Why?
|
| Isoquinolines | 1 | 2011 | 352 | 0.330 |
Why?
|
| Alzheimer Disease | 7 | 2024 | 8592 | 0.320 |
Why?
|
| Parietal Lobe | 2 | 2013 | 851 | 0.320 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2011 | 240 | 0.320 |
Why?
|
| Space Perception | 3 | 2007 | 465 | 0.320 |
Why?
|
| Humans | 123 | 2024 | 761326 | 0.320 |
Why?
|
| Malformations of Cortical Development | 1 | 2011 | 176 | 0.320 |
Why?
|
| Rest | 2 | 2013 | 919 | 0.310 |
Why?
|
| Combat Disorders | 1 | 2010 | 301 | 0.310 |
Why?
|
| Meningioma | 1 | 2017 | 1218 | 0.310 |
Why?
|
| Neural Pathways | 5 | 2012 | 3057 | 0.300 |
Why?
|
| Premenstrual Syndrome | 2 | 2008 | 109 | 0.300 |
Why?
|
| Brain Diseases | 3 | 2023 | 1545 | 0.290 |
Why?
|
| Delirium | 1 | 2019 | 1667 | 0.290 |
Why?
|
| Image Processing, Computer-Assisted | 19 | 2016 | 8997 | 0.290 |
Why?
|
| Functional Laterality | 8 | 2011 | 2256 | 0.290 |
Why?
|
| Depressive Disorder, Major | 3 | 2019 | 4760 | 0.280 |
Why?
|
| Basal Ganglia | 2 | 2007 | 554 | 0.280 |
Why?
|
| Sound | 3 | 2005 | 257 | 0.280 |
Why?
|
| Oxygen | 7 | 2015 | 4227 | 0.280 |
Why?
|
| Health Policy | 1 | 2019 | 2684 | 0.270 |
Why?
|
| Parahippocampal Gyrus | 3 | 2015 | 115 | 0.270 |
Why?
|
| Psychoanalytic Theory | 2 | 2004 | 138 | 0.260 |
Why?
|
| Public Health | 1 | 2019 | 2667 | 0.260 |
Why?
|
| Cerebrovascular Circulation | 9 | 2005 | 2727 | 0.250 |
Why?
|
| Neuroanatomy | 1 | 2005 | 70 | 0.250 |
Why?
|
| Tourette Syndrome | 2 | 2006 | 395 | 0.240 |
Why?
|
| Brain Stem | 2 | 2010 | 858 | 0.240 |
Why?
|
| Motivation | 1 | 2015 | 2006 | 0.240 |
Why?
|
| Mesencephalon | 3 | 2022 | 332 | 0.240 |
Why?
|
| Neuropsychological Tests | 11 | 2021 | 7045 | 0.230 |
Why?
|
| Psychotic Disorders | 3 | 2015 | 3223 | 0.230 |
Why?
|
| Rotation | 1 | 2006 | 517 | 0.230 |
Why?
|
| Saliva | 1 | 2009 | 827 | 0.230 |
Why?
|
| Depressive Disorder | 5 | 2006 | 3728 | 0.230 |
Why?
|
| Adaptation, Psychological | 1 | 2015 | 2630 | 0.230 |
Why?
|
| Psychoanalysis | 1 | 2004 | 89 | 0.220 |
Why?
|
| Stress Disorders, Post-Traumatic | 6 | 2020 | 4579 | 0.220 |
Why?
|
| Adult | 59 | 2024 | 221122 | 0.220 |
Why?
|
| Auditory Cortex | 3 | 2002 | 363 | 0.220 |
Why?
|
| Reaction Time | 5 | 2015 | 2080 | 0.220 |
Why?
|
| Cerebral Cortex | 10 | 2022 | 5776 | 0.210 |
Why?
|
| Cognition | 6 | 2021 | 6987 | 0.210 |
Why?
|
| Substantia Nigra | 2 | 2020 | 350 | 0.210 |
Why?
|
| Neurology | 2 | 2023 | 778 | 0.210 |
Why?
|
| Motor Cortex | 5 | 2007 | 1006 | 0.210 |
Why?
|
| Ethicists | 1 | 2022 | 39 | 0.210 |
Why?
|
| Female | 64 | 2024 | 392485 | 0.210 |
Why?
|
| Photic Stimulation | 7 | 2022 | 1985 | 0.200 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 5439 | 0.200 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3080 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3200 | 0.200 |
Why?
|
| Multiple Sclerosis | 3 | 2024 | 3222 | 0.200 |
Why?
|
| Magnetoencephalography | 3 | 2001 | 636 | 0.200 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 1 | 2022 | 38 | 0.200 |
Why?
|
| Visual Perception | 2 | 2015 | 1385 | 0.200 |
Why?
|
| Movement | 3 | 2007 | 1478 | 0.190 |
Why?
|
| Male | 66 | 2024 | 360621 | 0.190 |
Why?
|
| Electroencephalography | 6 | 2024 | 6224 | 0.190 |
Why?
|
| Antidepressive Agents | 2 | 2013 | 2897 | 0.190 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2022 | 102 | 0.190 |
Why?
|
| Oxygen Radioisotopes | 6 | 2001 | 75 | 0.180 |
Why?
|
| Psychoanalytic Therapy | 1 | 2003 | 228 | 0.180 |
Why?
|
| Putamen | 1 | 2022 | 292 | 0.180 |
Why?
|
| Psychophysiology | 2 | 2015 | 136 | 0.180 |
Why?
|
| Diagnostic Imaging | 2 | 2006 | 3531 | 0.170 |
Why?
|
| Septal Nuclei | 1 | 2020 | 85 | 0.170 |
Why?
|
| Anxiety | 4 | 2024 | 4571 | 0.170 |
Why?
|
| Volition | 2 | 2000 | 62 | 0.170 |
Why?
|
| Socialization | 1 | 2019 | 87 | 0.170 |
Why?
|
| Affect | 2 | 2006 | 1485 | 0.170 |
Why?
|
| Artifacts | 5 | 2005 | 1910 | 0.170 |
Why?
|
| Mental Recall | 3 | 2020 | 1214 | 0.170 |
Why?
|
| Caudate Nucleus | 1 | 2000 | 389 | 0.160 |
Why?
|
| Lewy Body Disease | 1 | 2022 | 252 | 0.160 |
Why?
|
| Bioethical Issues | 1 | 2020 | 120 | 0.160 |
Why?
|
| Comorbidity | 4 | 2019 | 10498 | 0.160 |
Why?
|
| Middle Aged | 37 | 2024 | 220774 | 0.160 |
Why?
|
| Interprofessional Relations | 1 | 2004 | 991 | 0.160 |
Why?
|
| Diagnosis, Differential | 5 | 2019 | 12972 | 0.150 |
Why?
|
| Facial Expression | 1 | 2022 | 508 | 0.150 |
Why?
|
| Cognition Disorders | 4 | 2011 | 3979 | 0.150 |
Why?
|
| Verbal Learning | 3 | 2008 | 463 | 0.150 |
Why?
|
| Neuroglia | 1 | 2024 | 955 | 0.150 |
Why?
|
| Neural Inhibition | 3 | 2007 | 590 | 0.150 |
Why?
|
| Stress, Psychological | 2 | 2014 | 4477 | 0.150 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 5 | 2011 | 1066 | 0.140 |
Why?
|
| Fluorine Radioisotopes | 2 | 2019 | 418 | 0.140 |
Why?
|
| Social Isolation | 1 | 2020 | 364 | 0.140 |
Why?
|
| Language | 3 | 2022 | 1539 | 0.140 |
Why?
|
| Deglutition Disorders | 1 | 2023 | 627 | 0.140 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2019 | 254 | 0.140 |
Why?
|
| Consciousness | 2 | 2000 | 601 | 0.130 |
Why?
|
| Acoustic Stimulation | 5 | 2005 | 1235 | 0.130 |
Why?
|
| Endophenotypes | 1 | 2017 | 255 | 0.120 |
Why?
|
| Receptors, GABA-A | 2 | 2015 | 623 | 0.120 |
Why?
|
| Memory, Short-Term | 1 | 2021 | 982 | 0.120 |
Why?
|
| Reward | 2 | 2015 | 971 | 0.120 |
Why?
|
| Arousal | 4 | 2007 | 1166 | 0.110 |
Why?
|
| Minority Groups | 1 | 2021 | 1203 | 0.110 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2019 | 555 | 0.110 |
Why?
|
| Optic Nerve | 1 | 2017 | 572 | 0.110 |
Why?
|
| Psychology | 1 | 2015 | 356 | 0.110 |
Why?
|
| Social Stigma | 1 | 2020 | 769 | 0.110 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 849 | 0.110 |
Why?
|
| Blindness | 1 | 2017 | 584 | 0.110 |
Why?
|
| Menstrual Cycle | 2 | 2008 | 539 | 0.110 |
Why?
|
| Fatigue | 1 | 2020 | 1551 | 0.110 |
Why?
|
| Social Behavior | 1 | 2019 | 1134 | 0.110 |
Why?
|
| Delusions | 1 | 2015 | 298 | 0.110 |
Why?
|
| Bipolar Disorder | 2 | 2000 | 5091 | 0.110 |
Why?
|
| Epilepsies, Partial | 1 | 2016 | 431 | 0.100 |
Why?
|
| Reading | 3 | 2022 | 529 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2024 | 6019 | 0.100 |
Why?
|
| Neocortex | 1 | 2015 | 417 | 0.100 |
Why?
|
| Behavior, Animal | 1 | 2019 | 1878 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2870 | 0.100 |
Why?
|
| Imagination | 2 | 2007 | 226 | 0.100 |
Why?
|
| Microglia | 1 | 2020 | 1357 | 0.100 |
Why?
|
| Auditory Perceptual Disorders | 2 | 2005 | 36 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2017 | 1567 | 0.090 |
Why?
|
| Seizures | 1 | 2024 | 2956 | 0.090 |
Why?
|
| Pilot Projects | 4 | 2019 | 8632 | 0.090 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 2717 | 0.090 |
Why?
|
| Vocabulary | 1 | 2011 | 165 | 0.090 |
Why?
|
| Follicular Phase | 2 | 2007 | 143 | 0.090 |
Why?
|
| Residence Characteristics | 1 | 2020 | 2092 | 0.090 |
Why?
|
| Luteal Phase | 2 | 2007 | 138 | 0.090 |
Why?
|
| Pattern Recognition, Visual | 2 | 2006 | 820 | 0.090 |
Why?
|
| Parkinson Disease | 2 | 2022 | 2876 | 0.090 |
Why?
|
| Galvanic Skin Response | 2 | 2012 | 357 | 0.080 |
Why?
|
| Echo-Planar Imaging | 2 | 2005 | 663 | 0.080 |
Why?
|
| Psychotherapy, Brief | 1 | 2010 | 118 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2017 | 2770 | 0.080 |
Why?
|
| Chromosome Mapping | 1 | 2017 | 4638 | 0.080 |
Why?
|
| Neoplasms | 1 | 2017 | 22158 | 0.080 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 943 | 0.080 |
Why?
|
| Neuronal Plasticity | 2 | 2014 | 1435 | 0.080 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2009 | 105 | 0.080 |
Why?
|
| Conditioning, Classical | 1 | 2010 | 368 | 0.070 |
Why?
|
| Corpus Striatum | 2 | 2007 | 1235 | 0.070 |
Why?
|
| Behavior | 2 | 2009 | 540 | 0.070 |
Why?
|
| Pons | 2 | 2006 | 240 | 0.070 |
Why?
|
| Reticular Formation | 1 | 2006 | 59 | 0.070 |
Why?
|
| Veterans | 1 | 2020 | 2647 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 7824 | 0.070 |
Why?
|
| Forecasting | 2 | 2006 | 2928 | 0.070 |
Why?
|
| Antipsychotic Agents | 1 | 2019 | 3067 | 0.070 |
Why?
|
| Raphe Nuclei | 1 | 2006 | 103 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 7597 | 0.060 |
Why?
|
| Mental Health | 1 | 2020 | 3248 | 0.060 |
Why?
|
| Cerebrovascular Disorders | 4 | 1997 | 1475 | 0.060 |
Why?
|
| Speech Perception | 3 | 2001 | 507 | 0.060 |
Why?
|
| Syndrome | 1 | 2012 | 3268 | 0.060 |
Why?
|
| Peroxides | 1 | 2005 | 74 | 0.060 |
Why?
|
| Attention | 6 | 2003 | 2395 | 0.060 |
Why?
|
| Memory Disorders | 2 | 2023 | 1198 | 0.060 |
Why?
|
| Ventral Tegmental Area | 1 | 2006 | 136 | 0.060 |
Why?
|
| Orientation | 1 | 2006 | 321 | 0.060 |
Why?
|
| Severity of Illness Index | 4 | 2020 | 15835 | 0.060 |
Why?
|
| Personality Inventory | 1 | 2007 | 1019 | 0.060 |
Why?
|
| Young Adult | 9 | 2024 | 59196 | 0.060 |
Why?
|
| Defense Mechanisms | 1 | 2004 | 180 | 0.060 |
Why?
|
| Inflammation | 1 | 2024 | 10760 | 0.060 |
Why?
|
| Paranoid Disorders | 1 | 2024 | 61 | 0.060 |
Why?
|
| Hypertrophy | 1 | 2006 | 559 | 0.060 |
Why?
|
| Locus Coeruleus | 1 | 2006 | 230 | 0.060 |
Why?
|
| Adolescent | 9 | 2022 | 88305 | 0.060 |
Why?
|
| Nucleus Accumbens | 1 | 2006 | 366 | 0.060 |
Why?
|
| Afferent Pathways | 1 | 2005 | 298 | 0.060 |
Why?
|
| Dreams | 1 | 2004 | 146 | 0.050 |
Why?
|
| Mental Health Services | 1 | 2015 | 1730 | 0.050 |
Why?
|
| Speech | 3 | 2000 | 554 | 0.050 |
Why?
|
| Models, Biological | 1 | 2019 | 9468 | 0.050 |
Why?
|
| Spectrum Analysis | 1 | 2005 | 451 | 0.050 |
Why?
|
| Internal-External Control | 1 | 2005 | 359 | 0.050 |
Why?
|
| Urea | 1 | 2005 | 444 | 0.050 |
Why?
|
| Breast Neoplasms | 2 | 2021 | 21009 | 0.050 |
Why?
|
| Regional Blood Flow | 4 | 1999 | 1495 | 0.050 |
Why?
|
| Telemedicine | 1 | 2020 | 3041 | 0.050 |
Why?
|
| Motion Perception | 1 | 2006 | 374 | 0.050 |
Why?
|
| Task Performance and Analysis | 1 | 2006 | 761 | 0.050 |
Why?
|
| Image Enhancement | 2 | 2003 | 2884 | 0.050 |
Why?
|
| Minisatellite Repeats | 1 | 2003 | 164 | 0.050 |
Why?
|
| Aged | 15 | 2024 | 169179 | 0.050 |
Why?
|
| GABA Modulators | 2 | 2000 | 109 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3806 | 0.050 |
Why?
|
| Choice Behavior | 1 | 2007 | 824 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2016 | 9319 | 0.050 |
Why?
|
| Military Personnel | 1 | 2010 | 1246 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2011 | 2650 | 0.050 |
Why?
|
| Visual Pathways | 1 | 2005 | 551 | 0.050 |
Why?
|
| Spin Labels | 4 | 2005 | 337 | 0.050 |
Why?
|
| Amnesia | 1 | 2023 | 255 | 0.050 |
Why?
|
| Hemodynamics | 2 | 2002 | 4167 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 5841 | 0.040 |
Why?
|
| Water | 2 | 1999 | 1410 | 0.040 |
Why?
|
| Hearing Loss, Central | 1 | 2000 | 14 | 0.040 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2003 | 485 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2005 | 1735 | 0.040 |
Why?
|
| Hospitalization | 1 | 2020 | 10715 | 0.040 |
Why?
|
| Hostility | 1 | 2021 | 183 | 0.040 |
Why?
|
| Geriatric Assessment | 4 | 2001 | 1409 | 0.040 |
Why?
|
| Flumazenil | 1 | 2000 | 84 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8635 | 0.040 |
Why?
|
| Tics | 1 | 2000 | 74 | 0.040 |
Why?
|
| Social Environment | 1 | 2005 | 1020 | 0.040 |
Why?
|
| Patient Care Team | 2 | 2015 | 2523 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2000 | 370 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2005 | 2048 | 0.040 |
Why?
|
| Acetanilides | 1 | 2020 | 169 | 0.040 |
Why?
|
| Linguistics | 1 | 1999 | 108 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2019 | 621 | 0.040 |
Why?
|
| Environment | 1 | 2005 | 1122 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2010 | 2053 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2015 | 4685 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2004 | 2358 | 0.040 |
Why?
|
| Auditory Pathways | 1 | 2000 | 237 | 0.040 |
Why?
|
| Schizophrenic Psychology | 2 | 2015 | 1647 | 0.040 |
Why?
|
| Reference Values | 3 | 2001 | 4921 | 0.040 |
Why?
|
| Music | 1 | 2001 | 245 | 0.040 |
Why?
|
| Temporal Lobe | 2 | 2022 | 1695 | 0.040 |
Why?
|
| Primates | 1 | 2000 | 524 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2020 | 551 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 2574 | 0.040 |
Why?
|
| Midazolam | 1 | 1998 | 266 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 2691 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2005 | 6231 | 0.030 |
Why?
|
| Case-Control Studies | 4 | 2016 | 22124 | 0.030 |
Why?
|
| Atrophy | 1 | 2021 | 1632 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2020 | 700 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 2000 | 1033 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2003 | 1496 | 0.030 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 1997 | 253 | 0.030 |
Why?
|
| Learning | 1 | 2005 | 1740 | 0.030 |
Why?
|
| Agnosia | 1 | 1995 | 66 | 0.030 |
Why?
|
| Language Tests | 1 | 2015 | 190 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2006 | 20092 | 0.030 |
Why?
|
| Periaqueductal Gray | 1 | 2015 | 110 | 0.030 |
Why?
|
| Event-Related Potentials, P300 | 1 | 1995 | 149 | 0.030 |
Why?
|
| Globus Pallidus | 1 | 1996 | 250 | 0.030 |
Why?
|
| Radioisotopes | 1 | 1996 | 499 | 0.030 |
Why?
|
| Deafness | 1 | 1998 | 459 | 0.030 |
Why?
|
| Algorithms | 4 | 2003 | 14025 | 0.030 |
Why?
|
| Psychometrics | 1 | 2024 | 3064 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 2000 | 1037 | 0.030 |
Why?
|
| Aphasia | 1 | 2015 | 192 | 0.030 |
Why?
|
| Time Factors | 5 | 2016 | 39974 | 0.030 |
Why?
|
| Family Therapy | 1 | 2015 | 215 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2022 | 2123 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2024 | 54405 | 0.030 |
Why?
|
| Thinking | 1 | 1996 | 320 | 0.030 |
Why?
|
| Electricity | 1 | 1993 | 181 | 0.030 |
Why?
|
| United States | 1 | 2020 | 72317 | 0.020 |
Why?
|
| Skin | 1 | 2005 | 4482 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2003 | 2790 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 3512 | 0.020 |
Why?
|
| Psychotherapy, Group | 1 | 2015 | 412 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 6210 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2021 | 3108 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2003 | 3356 | 0.020 |
Why?
|
| Motor Neurons | 1 | 1995 | 869 | 0.020 |
Why?
|
| Risk Factors | 2 | 2016 | 74152 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2023 | 3836 | 0.020 |
Why?
|
| Curriculum | 1 | 2003 | 3741 | 0.020 |
Why?
|
| Animals | 6 | 2019 | 168388 | 0.020 |
Why?
|
| Carnitine | 1 | 1990 | 252 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 1997 | 1161 | 0.020 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2015 | 942 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2015 | 64645 | 0.020 |
Why?
|
| Child | 3 | 2020 | 80156 | 0.020 |
Why?
|
| Physicians | 1 | 2024 | 4591 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 3357 | 0.020 |
Why?
|
| Mathematics | 1 | 2006 | 707 | 0.020 |
Why?
|
| Fingers | 2 | 2000 | 507 | 0.020 |
Why?
|
| Age Factors | 1 | 2001 | 18401 | 0.010 |
Why?
|
| Depression | 1 | 2024 | 8122 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2015 | 2775 | 0.010 |
Why?
|
| Motor Activity | 3 | 2002 | 2710 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 14597 | 0.010 |
Why?
|
| Sensitivity and Specificity | 3 | 2003 | 14665 | 0.010 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2003 | 170 | 0.010 |
Why?
|
| Boston | 1 | 2015 | 9333 | 0.010 |
Why?
|
| Hemorheology | 1 | 2002 | 144 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2015 | 3243 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 22154 | 0.010 |
Why?
|
| Linear Models | 2 | 2005 | 5871 | 0.010 |
Why?
|
| Tape Recording | 1 | 2000 | 77 | 0.010 |
Why?
|
| Stereotypic Movement Disorder | 1 | 2000 | 30 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18234 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 39108 | 0.010 |
Why?
|
| Sample Size | 1 | 2003 | 839 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 26108 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2006 | 1399 | 0.010 |
Why?
|
| Audiometry | 1 | 2000 | 253 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 15262 | 0.010 |
Why?
|
| Computer Simulation | 2 | 2003 | 6236 | 0.010 |
Why?
|
| Inpatients | 1 | 2010 | 2548 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 2000 | 518 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2002 | 1370 | 0.010 |
Why?
|
| Stereotaxic Techniques | 1 | 2000 | 555 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 5334 | 0.010 |
Why?
|
| Guilt | 1 | 1997 | 96 | 0.010 |
Why?
|
| Psychomotor Disorders | 1 | 1997 | 149 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 1996 | 333 | 0.010 |
Why?
|
| Audiometry, Pure-Tone | 1 | 1995 | 210 | 0.010 |
Why?
|
| Demyelinating Diseases | 1 | 1997 | 351 | 0.010 |
Why?
|
| Psychomotor Agitation | 1 | 1997 | 305 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2003 | 2524 | 0.010 |
Why?
|
| Violence | 1 | 1999 | 937 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 80575 | 0.010 |
Why?
|
| Mice | 1 | 2019 | 81474 | 0.010 |
Why?
|
| Sex Factors | 1 | 2006 | 10551 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2015 | 41440 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1996 | 2265 | 0.010 |
Why?
|
| Hearing | 1 | 1995 | 501 | 0.010 |
Why?
|
| Arm | 1 | 1995 | 590 | 0.010 |
Why?
|
| Rats, Inbred SHR | 1 | 1990 | 186 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2002 | 3577 | 0.010 |
Why?
|
| Electromyography | 1 | 1995 | 1393 | 0.010 |
Why?
|
| Age of Onset | 1 | 1997 | 3303 | 0.010 |
Why?
|
| Leg | 1 | 1995 | 1089 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 1997 | 1836 | 0.010 |
Why?
|
| Thalamus | 1 | 1995 | 1044 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1996 | 2009 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1990 | 2498 | 0.000 |
Why?
|
| Arteries | 1 | 1990 | 1125 | 0.000 |
Why?
|
| Neurons | 1 | 2003 | 9458 | 0.000 |
Why?
|
| Disease Progression | 1 | 1997 | 13500 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2003 | 42251 | 0.000 |
Why?
|
| Stroke | 1 | 2000 | 9749 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1990 | 8485 | 0.000 |
Why?
|
| Rats | 1 | 1990 | 23729 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1997 | 58946 | 0.000 |
Why?
|